The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Zaynich
zidebactam dihydrate and cefepime hydrochloride · ZIDEBACTAM DIHYDRATE 1 g/1; CEFEPIME HYDROCHLORIDE 2 g/1 · Injection, Powder, For Solution · Intravenous · Wockhardt Suisse USA LLC
NDC 87706-0866-01 · 1 VIAL, SINGLE-DOSE in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- ACS Dobfar SpAItalyanalysis · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA220787
- TE code
- —
- Approval date
- May 29, 2026
- Patents / exclusivity
- 7 patents, 2 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| exclusivity | GAIN | May 29, 2036 |
| exclusivity | NCE | May 29, 2031 |
| patent | 9657021 | Oct 12, 2033 |
| patent | 9834557 | Oct 12, 2033 |
| patent | 8822450 | Aug 24, 2032 |
| patent | 8853197 | Aug 24, 2032 |
| patent | 9827235 | Aug 24, 2032 |
| patent | 9132133 | Aug 24, 2032 |
| patent | 9381200 | Aug 24, 2032 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of zidebactam dihydrate and cefepime hydrochloride (Injection, Powder, For Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Wockhardt Suisse USA LLC | ZIDEBACTAM DIHYDRATE 1 g/1; CEFEPIME HYDROCHLORIDE 2 g/1 | Aug 26, 2026 | Sep 2, 2026 |
| Wockhardt Suisse USA LLC | ZIDEBACTAM DIHYDRATE 2 g/1; CEFEPIME HYDROCHLORIDE 1 g/1 | Jul 22, 2026 | Aug 19, 2026 |
| Wockhardt Suisse USA LLC | CEFEPIME HYDROCHLORIDE 2 g/1; ZIDEBACTAM DIHYDRATE 1 g/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Zaynich — NDC 87706-0866-01," retrieved September 3, 2026, https://drugdashboards.com/drug/87706086601.
Free to cite with attribution — see how the data is put together.